About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

[11C]raclopride

Company: Yale University
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 5, 2026

Trial details

Recruiting NCT NCT05282277

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

Not yet reported University of North Carolina, Chapel Hill 103 participants Est. completion 2026-12-31 1 site

Other conditions: Depression, Psychosis, Anhedonia
View official trial listing →
Recruiting NCT NCT07559500

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 176 participants Est. completion 2031-12-31 1 site

Alcohol use disorder
View official trial listing →
Recruiting NCT NCT07732426

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Not yet reported Seoul National University Hospital 30 participants Est. completion 2028-06-30 1 site

Other conditions: Food Addiction Tendency, Obesity, Overweight
View official trial listing →
Completed NCT NCT00024960

Dopamine Function in Developmental Stuttering

National Institute on Deafness and Other Communication Disorders (NIDCD) 12 participants Est. completion 2010-10-29 1 site

Other conditions: Developmental Stuttering
View official trial listing →
Completed NCT NCT00392743

A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

GlaxoSmithKline 60 participants Est. completion 2007-05 7 sites

Other conditions: Schizophrenia
View official trial listing →
Completed NCT NCT00480246

A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer

Not yet reported BioLineRx, Ltd. 1 site

Other conditions: Healthy
View official trial listing →
Terminated NCT NCT00562198

PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

Not yet reported Orion Corporation, Orion Pharma 16 participants Est. completion 2008-05 5 sites

Other conditions: Parkinson´s Disease
View official trial listing →
Completed NCT NCT00670293

Changes in Dopamine Levels Before and After Weight Restoration in People With Anorexia Nervosa

New York State Psychiatric Institute 50 participants Est. completion 2015-12 1 site

Other conditions: Eating Disorders
View official trial listing →
Completed NCT NCT00716755

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Not yet reported Centre for Addiction and Mental Health 45 participants Est. completion 2015-08 1 site

Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Psychotic Disorder
View official trial listing →
Status unknown NCT NCT00825045

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Not yet reported Centre for Addiction and Mental Health 14 participants Est. completion 2020-12 1 site

Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
View official trial listing →
Completed NCT NCT00832221

Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL

Not yet reported AstraZeneca 10 participants Est. completion 2009-09 1 site

Other conditions: Depression
View official trial listing →
Completed NCT NCT00846339

PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration

Not yet reported Seoul National University Hospital 12 participants Est. completion 2009-06 1 site

Other conditions: Smoking
View official trial listing →
Completed NCT NCT02020408

Monoamine Contributions to Neurocircuitry in Eating Disorders

Not yet reported University of California, San Diego 88 participants Est. completion 2017-12-31 1 site

Other conditions: Eating Disorder
View official trial listing →
Completed NCT NCT02061722

[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.

Not yet reported CHDI Foundation, Inc. 90 participants Est. completion 2016-05 8 sites

Other conditions: Huntington's Disease
View official trial listing →
Terminated NCT NCT02148783

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

Not yet reported Uniformed Services University of the Health Sciences 11 participants Est. completion 2018-08 1 site

Other conditions: Traumatic Brain Injury
View official trial listing →
Terminated NCT NCT02152670

Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET

Not yet reported Yale University 1 participants Est. completion 2014-06-09 1 site

Other conditions: Cocaine Dependence
View official trial listing →
Completed NCT NCT02169310

Neural Basis of Decision-Making Deficits in Traumatic Brain Injury

Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 45 participants Est. completion 2024-02-13 1 site

Other conditions: Traumatic Brain Injury
View official trial listing →
Withdrawn NCT NCT02233829

Dopamine Rhythms in Health and Addiction

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) Est. completion 2024-04-23 1 site

Other conditions: Cocaine Abuse
View official trial listing →
Completed NCT NCT02333487

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

Not yet reported H. Lundbeck A/S 22 participants Est. completion 2016-02-11 1 site

Other conditions: Schizophrenia
View official trial listing →
Completed NCT NCT03190954

Brain Dopaminergic Signaling in Opioid Use Disorders

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 153 participants Est. completion 2025-10-27 1 site

Substance use disorder Other conditions: Normal Physiology
View official trial listing →
Completed NCT NCT03326245

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

Not yet reported National Institute on Alcohol Abuse and Alcoholism (NIAAA) 25 participants Est. completion 2024-02-08 1 site

Other conditions: Normal Physiology
View official trial listing →
Completed NCT NCT03637075

Raclopride-PET/MRT

Not yet reported University Hospital Tuebingen 24 participants Est. completion 2023-12-31 1 site

Type 2 diabetes
View official trial listing →
Completed NCT NCT03648892

Brain Dopamine Function in Human Obesity

Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 61 participants Est. completion 2023-02-17 1 site

Other conditions: Obesity, Healthy Volunteers, Overweight
View official trial listing →
Withdrawn NCT NCT03999190

Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia

NYU Langone Health Est. completion 2025-07 1 site

Other conditions: Schizophrenia
View official trial listing →
Active, not recruiting NCT NCT05359887

PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery

Not yet reported University Medical Center Groningen 30 participants Est. completion 2026-12-31 1 site

Other conditions: Obesity
View official trial listing →
Completed NCT NCT06299410

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Not yet reported Intra-Cellular Therapies, Inc. 58 participants Est. completion 2026-08-18 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Not yet recruiting NCT NCT06977308

A Multimodal Imaging Study of Dopamine in Early Psychosis

Not yet reported New York State Psychiatric Institute 115 participants Est. completion 2030-10-01

Other conditions: Clinical High Risk for Psychosis (CHR)
View official trial listing →
Not yet recruiting NCT NCT07915986

Brain Dopamine Dynamics in Obesity

Not yet reported Yale University 100 participants Est. completion 2029-11 1 site

Other conditions: Obesity
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT07915986

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.